CBP501 inhibits EGF-dependent cell migration, invasion and epithelial-to-mesenchymal transition of non-small cell lung cancer cells by blocking KRas to calmodulin binding.
CBP501 inhibits EGF-dependent cell migration, invasion and epithelial-to-mesenchymal transition of non-small cell lung cancer cells by blocking KRas to calmodulin binding. — المؤلف: Saito, Naoya — Oncotarget Sep 2017
- المؤلف
- Saito, Naoya
- النشر
- Oncotarget Sep 2017
- الوصف
- 74006-74018 p.